thank
dr
weijer
koolwijk
van
hinsbergh
van
nieuw
amerongen
interest
recent
public
bind
domain
fibrinogen
induc
endotheli
barrier
permeabl
enhanc
transendotheli
migrat
malign
breast
epitheli
cell
appear
august
issu
intern
journal
cancer
moreov
appreci
concern
rais
weijer
et
effect
observ
endotheli
permeabl
malign
breast
epitheli
cell
transendotheli
cell
migrat
due
thrombinproteolyt
convers
exogen
ad
fibrinogen
fibrin
monom
andor
fibrin
ogen
degrad
product
due
exposur
cryptic
vascular
endotheli
bind
domain
locat
residu
chain
intact
fibrinogen
although
role
regul
endotheli
cell
permeabl
well
role
intact
fibrinogen
absenc
convers
fibrin
andor
fibrin
ogen
degrad
product
promot
endotheli
cell
permeabl
would
unexpect
initi
studi
also
expect
fibrin
monom
fibrin
ogen
degrad
product
previous
report
literatur
cite
weijer
et
would
induc
permeabl
barrier
endothelium
commerci
purchas
highli
purifi
fibrinogen
use
studi
subject
addit
rigor
qualiti
control
although
small
amount
fibrin
fibrin
ii
well
fibrin
ogen
degrad
product
found
commerci
sourc
purifi
human
fibrinogen
prepar
pool
plasma
convinc
neglig
contamin
fibrin
monom
andor
fibrin
ogen
degrad
product
account
effect
weijer
et
rais
possibl
intact
fibrinogen
convert
fibrin
thrombin
ad
condit
medium
cultur
endotheli
cell
address
concern
show
addit
data
collect
control
experi
cours
studi
fig
determin
whether
thrombin
activ
affect
permeabl
induc
intact
fibrinogen
assess
flux
across
endotheli
barrier
absenc
presenc
specif
thrombin
inhibitor
hirudin
shown
figur
unitml
hirudin
effect
flux
across
endotheli
barrier
p
student
indic
activ
thrombin
particip
endotheli
permeabl
higher
concentr
hirudin
unitsml
also
effect
endotheli
barrier
permeabl
unpublish
data
address
suggest
solubl
intact
fibrinogen
convert
fibrin
andor
fibrin
ogen
degrad
product
malign
breast
epitheli
cell
show
data
collect
dr
brian
rybarczyk
publish
doctor
iodin
fibrinogen
expos
cell
hr
remain
intact
kda
cleav
thrombin
crosslink
form
fibrin
ogen
polym
typic
proteolyt
degrad
product
eg
fragment
e
observ
fig
data
publish
laboratori
indic
fibrinogen
ad
exogen
fibroblast
pleas
see
fig
endogen
produc
lung
epitheli
cell
pleas
see
fig
remain
intact
addit
data
laboratori
suggest
fibrinogen
interact
cell
surfac
integrin
either
directli
indirectli
associ
fibronectin
cell
surfac
heparan
sulfat
proteoglycan
hspg
wide
accept
residu
defin
cryptic
intact
monoclon
antibodi
bind
epitop
defin
residu
intact
fibrinogen
present
either
solut
adsorb
solid
surfac
howev
shown
highli
purifi
intact
fibrinogen
ad
solut
phase
metabol
activ
cell
cultur
fibrinogen
assembl
extracellular
matrix
absenc
proteolyt
cleavag
fibrin
fibrin
ogen
degrad
product
process
higher
order
structur
coval
fibrin
ogen
observ
use
primari
cell
human
foreskin
fibroblast
human
umbil
vein
endotheli
cell
well
human
cell
line
includ
lung
type
epitheli
cell
nonmalign
malign
breast
epitheli
cell
moreov
shown
conclus
expos
fibrillar
matrix
fibrinogen
recogn
monoclon
antibodi
fig
reproduc
permiss
blood
cover
photo
palumbo
et
perform
eleg
experi
mutant
mice
show
plasma
fibrin
ogen
thrombin
platelet
import
promot
metastasi
certain
cancer
lung
pertin
respons
result
show
mice
number
metastat
foci
melanoma
lewi
lung
carcinoma
greatli
reduc
weijer
et
rais
point
palumbo
colleagu
perform
experi
absenc
presenc
specif
thrombin
inhibitor
hirudin
lung
metastasi
reduc
mice
pleas
see
fig
howev
hirudin
also
decreas
lung
metastasi
compar
mice
pleas
see
fig
suggest
prometastat
affect
thrombin
part
fibrinogen
independ
well
known
thrombin
contribut
sever
cancer
progress
promot
tumor
angiogenesi
cancer
cell
prolifer
metastasi
mechan
thrombin
gener
fibrin
chain
defin
residu
particip
clot
format
also
implic
number
import
cellular
respons
includ
cell
stimul
cell
bind
support
bind
endotheli
cell
induc
cell
migrat
wound
shown
cryptic
heparan
bind
domain
map
residu
fibrin
ogen
bind
domain
heparan
bind
domain
fibrin
ogen
overlap
fibrinogen
chain
rule
possibl
endotheli
cell
surfac
hspg
play
role
intact
endotheli
permeabl
howev
consid
least
favor
interpret
data
bind
fibrin
monom
endotheli
cell
occur
endotheli
cell
fix
elisa
plate
cell
bind
assay
contrast
fibrinogen
bound
poorli
fix
endotheli
cell
cell
bind
furthermor
shown
fibrinogen
assembl
extracellular
matrix
requir
bind
cell
surfac
deposit
matrix
pleas
see
fig
cell
surfac
bind
integrin
depend
requir
fibrinogen
rgd
sequenc
howev
cell
surfac
bind
hspg
depend
also
known
still
assembl
matrix
fibril
pleas
see
fig
moreov
metabol
activ
cell
capabl
assembl
fibrinogen
matur
matrix
fibril
pleas
see
fig
taken
togeth
publish
data
support
conclus
absenc
malign
breast
cancer
cell
endotheli
barrier
permeabl
occur
intact
fibrinogen
bind
integrin
endotheli
cell
surfac
bind
induc
conform
chang
expos
fibrinogen
domain
thu
allow
bind
conclus
support
photomicrograph
fig
cover
photo
sahni
et
show
fibrinogen
assembl
subendotheli
matrix
fibril
bind
surfac
endotheli
cell
junction
found
agre
fibrin
thrombin
play
signific
physiolog
role
cancer
metastasi
howev
exact
structur
fibrin
ogen
fibrin
ogen
degrad
product
promot
endotheli
barrier
permeabl
poorli
understood
pose
intrigu
possibl
subphysiolog
level
fibrinogen
modul
cell
respons
microenviron
fibrinogen
tumor
cell
endothelium
interact
extens
research
laboratori
contribut
elucid
molecular
mechan
regul
gene
express
protein
biosynthesi
assembl
function
fibrinogen
produc
extrahepat
epithelium
lung
prostat
breast
use
adenocarcinoma
cell
other
report
express
fibrinogen
gene
secret
fibrinogen
protein
intestin
cervic
epitheli
cancer
cell
extrahepat
express
fibrinogen
occur
vivo
demonstr
anim
model
pneumocysti
carinii
pneumonia
gene
express
profil
biopsi
sampl
patient
lung
breast
function
signific
fibrinogen
express
extrahepat
epithelium
like
influenc
cellular
context
fibrinogen
found
rather
overal
plasma
concentr
summari
stand
interpret
exposur
bind
domain
intact
fibrinogen
induc
endotheli
cell
permeabl
promot
transendotheli
migrat
malign
breast
cancer
cell
furthermor
reason
hypothes
small
amount
fibrinogen
produc
endogen
breast
cancer
cell
contribut
tumor
cell
interact
promot
breast
cancer
metastasi
vivo
strike
observ
intact
fibrinogen
unabl
induc
barrier
endotheli
permeabl
presenc
nonmalign
breast
epitheli
cell
pleas
see
fig
discuss
led
us
hypothes
nonmalign
breast
epitheli
cell
bind
fibrinogen
sequenc
like
cell
surfac
hspg
render
bind
domain
fibrinogen
inaccess
abil
nonmalign
breast
epitheli
cell
bind
fibrinogen
loss
bind
capac
malign
breast
cancer
cell
suggest
molecular
mechan
premalign
breast
epitheli
cell
transform
highli
aggress
metastat
breast
cancer
phenotyp
studi
anim
model
breast
cancer
metastasi
permit
us
test
valid
hypothes
